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ABSTRACT
Introduction: Human adenoviruses (HAdV) play an important role in the aetiology of severe acute lower respiratory infection, 
especially in immunocompromised individuals. The aim of the present study was to detect HAdV using two different methods, 
direct fluorescence assay (DFA) and nested polymerase chain reaction (nested PCR), in samples collected from patients with acute 
respiratory infection (ARI) within 7 days of symptom onset. Methods: Samples (n=643) were collected from patients in different risk 
groups from 2001 to 2010: 139 adult emergency room patients (ERP); 205 health care workers (HCW); 69 renal transplant outpatients 
(RTO); and 230 patients in a haematopoietic stem cell transplantation program (HSCT). Results: Adenovirus was detected in 13.2% 
of the 643 patients tested by DFA and/or PCR: 6/139 (4.3%) adults in the ERP group, 7/205 (3.4%) in the HCW group, 4/69 (5.8%) 
in the RTO group and 68/230 (29.5%) in the HSCT patient group. Nested PCR had a higher detection rate (10%) compared with the 
DFA test (3.8%) (p<0.001). HSCT patients exhibited a significantly higher rate of HAdV infection. Conclusions: The adenovirus 
detection rate of the nested PCR assay was higher than that of the DFA test. However, the use of molecular methods in routine 
diagnostic laboratory work should be evaluated based on the specific circumstances of individual health services. 
Keywords: Human adenoviruses. Respiratory infection, Direct fluorescence assay. Nested PCR. 
Immunocompromised patients. Immunocompetent patients.
Adenoviruses play an important role in the aetiology of 
severe acute lower respiratory infection, especially in young 
children and immunocompromised individuals1. Human 
adenoviruses (HAdV) spread rapidly in closed environments 
and often cause epidemic disease in high-density communities2.
Health care workers (HCWs) are in direct contact with 
HAdV-infected patients, and this population is especially 
susceptible to infection with the virus, acting as a source of 
infection during outbreaks. Furthermore, there have been few 
studies in this population, and little is known about HAdV 
circulation in HCWs compared to community subjects3. 
In immunocompromised patients, especially stem cell 
and solid organ transplant patients, HAdV can cause severe 
infection, with mortalities ranging from 18-83%, depending 
on the nature of the immunosuppression4-8. In Brazil, there is a 
lack of sufficient information about the immunocompromised 
population, with detection ranging from 0-3% 3,9.
Furthermore, it is difficult to clinically distinguish adenovirus 
infection from other viral or bacterial respiratory infections10. 
Rapid diagnostic methods help to avoid inadequate antimicrobial 
treatment and support infection control interventions to limit 
nosocomial infections . Molecular methods demonstrate greater 
sensitivity than conventional assays for detecting adenovirus in 
respiratory samples11,12.
Brazilian studies have described HAdV frequencies of 3 to 
7.1%, as measured using different diagnostic techniques13-16. 
Outbreaks have been frequently reported among young 
patients17.
The aim of the present study was to assess the rate of HAdV 
detection achieved by different methods, namely the direct 
fluorescence assay (DFA) and nested polymerase chain reaction 
(nested PCR), from samples collected from different risk groups 
over a period of six years.
METHODS
Study population 
In the present study, samples from four different populations 
were collected from 2001 to 2010. 
Adult emergency room patients (ERP): From 2001 through 
2003, 139 adult patients from the general community were 
evaluated by general practitioners at the São Paulo Hospital 
emergency room.
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TABLE 1 - Demographic data of the study populations
   Samples              Gender male                         Age (years)
 n % n % mean±SD median range
HCWs 205 31.9 154 75.1 36.2±11.7 36.0 16-68
ERP 139 21.6 62 44.6 32.7±13.8 29.0 12-83
RTO 69 10.7 35 50.7 38.8±11.7 38.5 15-60
HSCT 230 35.8 132 57.4 43.7±15.2 47.0 18-80
Total 643 100.0 383 59.6 38.3±14.12 37.0 12-83
HCWs: health care workers; ERP: emergency room patients; RTO: renal transplant 
outpatients; HSCT: patients in a haematopoietic stem cell transplant program; SD: 
standard deviation.
Health care workers (HCWs): From 2001 through 2003, 205 
adult health care workers were evaluated by general practitioners 
in the Sao Paulo Hospital employee health support centre. 
Renal transplant outpatients (RTO): From 2001 through 
2003, 69 adult outpatients of the renal transplant clinic were 
evaluated.
Patients in a haematopoietic stem cell transplantation 
programme (HSCT): From 2008 to 2010, 230 adult patients 
attending the haematopoietic stem cell transplantation program 
of the São Paulo Hospital haematological service were 
evaluated. Samples were collected from all patients by a member 
of the medical staff, usually an infectious disease physician. Of 
the 230 patients in this group, information about transplantation 
was available for 221 (96%): 55.2% (122/221) of these patients 
were undergoing transplantation at the time of study enrolment, 
and 44.8% (99/221) were non-transplanted . 
Inclusion criteria
Adults (> 12 years old) presenting acute respiratory infection 
(ARI) of likely viral aetiology were eligible. Sample collection was 
performed within 7 days of symptom onset and after evaluation by a 
physician. The respiratory symptoms assessed were coryza, cough, 
sore throat, and nasal congestion, and the systemic symptoms 
assessed were fever, headache, malaise, chills, and fatigue.
Sample collection
Nasal wash (NW) specimens were collected from patients 
presenting with acute respiratory symptoms who were referred 
by physicians from São Paulo Hospital to the Clinical Virology 
Laboratory, São Paulo, Brazil18.
Adenovirus detection
All samples were maintained at 4°C and transported 
immediately to the laboratory. An aliquot (1 mL) was separated for 
molecular analysis and stored at -70°C. The remaining specimen 
volume was evaluated on the same day by direct fluorescence 
assay, as described in a previous study19. One aliquot from 
each stored sample was subjected to DNA extraction using the 
QIAamp DNA Blood extraction kit (Qiagen, USA) according to 
the manufacturer’s instructions, followed by nested PCR for the 
detection of all adenovirus serotypes, as previously described20.
Direct fluorescence (immunofluorescence) assay: All 
studied samples were evaluated using the direct fluorescence 
assay (DFA) . The tests were performed using the SimulFluor 
Respiratory Screen and Panel  (Chemicon Int., USA), in 
accordance with the manufacturer’s instructions.
Nested PCR assay: For the first amplification reaction (PCR 
product – 301 bp), 5 μL of extracted DNA was added to a tube 
with a reaction mixture consisting of 2.5 μL of 10X buffer (200 
mM Tris-HCl, pH 8.4, 500 mM KCl), 3.5 mM MgCl
2
, 0.5 μM of 
the primers Hex1deg and Hex2deg20 (Hex1deg - 5´- GCC SCA 
RTG GKC WTA CAT GCA CAT C - 3´, Hex2deg - 5´- CAG 
CAC SCC ICG RAT GTC AAA - 3´), 1 μL of a dNTP mixture 
containing 20 mM of each nucleotide, 2.5 U of Platinum® Taq 
DNA Polymerase (Invitrogen, Brazil) and autoclaved MilliQ 
water to a final volume of 25 μL.
For the second amplification reaction (PCR product - 171 bp), 
2 μL of the amplicon produced by the first reaction was added to 
a tube with a reaction mixture consisting of 2.5 μL of 10X buffer 
(200 mM Tris-HCl, pH 8.4, 500 mM KCl), 3.5 mM of MgCl
2
, 
0.5 μM of the primers Nehex3deg and Nehex4deg20 (Nehex3deg 
- 5´- GCC CGY GCM ACI GAI ACS TAC TTC - 3´, Nehex4deg 
- 5´- CCY ACR GCC AGI GTR WAI CGM RCY TTG TA - 3´), 
1 μL of a dNTP mixture containing 20 mM of each nucleotide, 
2.5 U of Platinum® Taq DNA Polymerase (Invitrogen, Brazil) and 
autoclaved MilliQ water to a final volume of 25 μL.
A positive control (Adenovirus Serotype 3) and a redundant 
negative control (autoclaved MilliQ water) were included in 
each series. A sample was considered positive when an amplicon 
could be visualised by 2% agarose gel electrophoresis.
The sensibility of the reaction was standardised and showed 
a detection limit of 10-4 TCID
50
/mL.
Statistical analysis
Between-group comparisons of different categorical 
variables were performed using the Chi-square test and non-
conditional multiple logistic regression (SPSS, version 11.5). 
A p value < 0.05 was considered to be statistically significant.
Ethical considerations
The present study was approved by the Ethics Committee 
of São Paulo Hospital and the Federal University of São Paulo 
(1654/09).
Samples from 643 symptomatic patients were analysed 
(40.4% females and 59.6% males). The demographic 
characteristics of all studied patients are shown in Table 1.
Among the 643 samples collected during the study period, 
85 (13.2%) were found to be HAdV positive by at least one 
test: 7/205 (3.4%) from the HCW group, 6/139 (4.3%) from 
the ERP group, 4/69 (5.8%) from the RTO group, and 68/230 
(29.6%) from the haematological patient group . Table 2 shows 
the differences in detection rates between assays in each of the 
different studied populations. Overall, 24 (3.8%) of 643 samples 
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DISCUSSION
TABLE 2 - Adenovirus detection by direct fluorescence assay and nested PCR 
assay among different studied populations from São Paulo from 2001-2010
  DFA Nested-PCR  Total 
 Number positive positive  positivity
     of samples n % n % p          n          %
HCWs 205a 0 0.0 7 3.4 0.015 7 3.4
ERP 139 0 0.0 6 4.3 0.030 6 4.3
RTO 69 0 0.0 4 5.8 0.12 4 5.8
HSCT 230b 24 10.4 47c 20.4 0.005 68 29.6
Total 643 24 3.8 64 10.0 < 0.001 85 13.2
PCR: polymerase chain reaction; DFA: direct fluorescence assay; HCWs: health care workers; 
ERP: emergency room patients; RTO: renal transplant outpatients; HSCT: patients in a 
haematopoietic stem cell transplant program. aDFA could not be performed in 8 samples; 
bDFA could not be performed in one sample; c Three samples tested positive in both 
tests and were counted as positive for nested PCR.
TABLE 3 - Time from symptom onset to sample collection, stratified according to direct 
fluorescence assay and nested PCR assay results
    Days
 < 5  > 5
 positive % total positive % Total
DFA 17 3.4 501   7   4.9 142
Nested-PCR 42 8.4 501 22 15.5 142
p-value  < 0.01   < 0.01
PCR: polymerase chain reaction; DFA: direct fluorescence assay. 
were DFA positive (10 had insufficient material for DFA), and 
64 (10%) of 643 samples were nested PCR positive (one sample 
had insufficient volume for nested PCR). 
The nested PCR assay achieved a significantly higher detection 
rate than the DFA assay among all studied populations, except for 
the renal transplanted outpatients group. When the entire studied 
population was analysed, the molecular method showed a higher 
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FIGURE 1 - Human adenovirus detection according to month/year of study.
detection rate than DFA (p < 0.001). The highest detection rate 
was found in HSCT patients (p < 0.001) . The distribution of 
positive samples along the period of study is shown in Figure 1.
The time from symptoms onset to sample collection was 
analysed and was found to be significantly different between 
DFA and nested PCR (Table 3). Compared to DFA, nested PCR 
detected a greater number of cases both in samples collected 
within five days of symptom onset and in samples collected 
between days 5 and 7. Within the HSCT group, nested PCR 
assay detection was higher in patients with more than five days 
between symptom onset and sample collection (p<0.001). 
HSCT patients exhibited a 12 times higher rate of HAdV 
infection than HCWs (p<0.001; CI: 5.37-26.9).
In Brazil, few studies have investigated adenovirus infection 
among immunocompetent non-hospitalised adults. The detection 
rates among the adult populations in this study (emergency 
room patients, 4.3%; health care workers, 3.4%) were similar to 
those described in the literature (2.5% - 12.8%)21,22. Lessa et al.22 
reported that 19% of HCWs in a military hospital were infected 
with HAdV, compared with 5.3% of non-HCWs.
Adenovirus infection is an important cause of morbidity and 
mortality among stem cell transplant recipients23,24. Hospitalised 
patients presenting haematological diseases, with prolonged 
hospital stays, are at a high risk of severe HAdV infection 
and represent a potential source of nosocomial outbreaks25. 
Studies have reported rates of HAdV infection ranging from
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2 to 21%, with a mortality rate of 10-60%, depending on the 
immunosuppressive regimen used26.
The evaluation of these two tests raised many questions that 
are important for both clinicians and hospital administrators: What 
is the ideal time of sample collection after sample onset? Is there a 
need for repeat testing? What is the ideal number of samples for a 
routine laboratory flow? What are the implications of negative or 
positive tests in high-risk patients? Some of these questions were 
addressed in the present study. HAdV was detected by at least 
one of the tests in 13% of the samples. Cases of HAdV occurred 
throughout the year, with higher detection rates obtained by DFA 
during 2008 March and April. This peak could be explained by an 
HAdV outbreak in the haematological ward that occurred during 
that period, as well as by the clinical re-evaluation to which these 
patients were submitted, i.e., the analysis of multiple samples 
from the same patients within the same month could have led to 
an overestimate of the virus occurrence.
The evaluation of patient symptom onset and the tests used 
showed that the molecular method was always more sensible 
than the DFA, and this difference was more evident for samples 
collected after the fifth day of symptom onset. Another study 
reported similar results, with molecular methods presenting 
higher sensitivity than DFA in adult patients27,28. The lower 
detection of DFA was related to the low viral load in respiratory 
samples29. 
Higher detection rates among patients with a longer period of 
symptom onset were expected due to the higher sensibility of the 
nested PCR30,31. The success of the DFA test relies on key factors 
such as good sample collection, experienced laboratory staff 
and high viral load29,32, while nested PCR, based on nucleic acid 
amplification, can detect a very low number of viral particles20. 
Among HSCT patients, nested PCR presented higher sensibility 
after the fifth day, suggesting that the molecular method is best 
for HAdV detection among patients with a prolonged infection 
history.
Adenoviruses can produce asymptomatic33,34 and prolonged34 
infections in humans. These two parameters must be considered 
when the diagnostic technique is selected. Carraro18 reported 
that there was no difference in influenza virus detection 
between DFA and RT-PCR up to the fifth day of symptom onset, 
indicating a reasonably good performance of the serological 
test during the acute phase of the disease. On the other hand, 
a positive result yielded by the molecular method does not 
necessarily indicate a symptomatic infection, mainly due to 
high sensibility of this test20. The use of quantitative PCR (real 
time PCR) could address this issue; the viral load can indicate 
the presence or absence of disease11.
All patients enrolled in the present study had acute 
respiratory infection, which reduces the possibility of 
asymptomatic infection by adenovirus. Moreover, all samples 
were collected within 7 days of symptom onset, and it was 
therefore not possible to analyse the duration of viral shedding.
One limitation of our study was the lack of analysis of 
possible co-infections with HAdV and other respiratory viruses. 
However, data from several studies showed low rates, ranging 
from 1.04% to 3.5%35-37.
Based on data obtained in the present evaluation, we 
concluded that the nested PCR assay had a higher HAdV detection 
frequency than the DFA, mainly among high-risk patients 
(haematopoietic stem cell transplant recipients). However, the 
choice to use molecular methods for HAdV detection in routine 
diagnosis should consider the economic reality of the specific 
health service and the demand for HAdV testing.
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